Ouabain improves functional recovery following traumatic brain injury

Journal of Neurotrauma

Volumn 31, Issue 23, 2014, Pages 1942-1947

  Dvela Levitt, Moran ^a   Ami, Hagit Cohen Ben ^a   Rosen, Haim ^a   Shohami, Esther ^a   Lichtstein, David ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Cardiac steroids; Cell viability; Closed head injury; Na+, K+ ATPase

Indexed keywords

OUABAIN; NEUROPROTECTIVE AGENT;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN SIZE; CELL PROLIFERATION; CONTROLLED STUDY; CONVALESCENCE; ENDOTHELIUM CELL; FUNCTIONAL STATUS; LOW DRUG DOSE; MALE; MOUSE; NERVE CELL; NERVE REGENERATION; NONHUMAN; SUBVENTRICULAR ZONE; TASK PERFORMANCE; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; ANIMAL; BRAIN INJURIES; DRUG EFFECTS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN INJURIES; CELL PROLIFERATION; MALE; MICE; NEUROPROTECTIVE AGENTS; OUABAIN; RECOVERY OF FUNCTION;

EID: 84911995644     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2014.3544     Document Type: Article

References (38)

1. Beauchamp, K., Mutlak, H., Smith, W.R., Shohami, E., and Stahel, P.F. (2008). Pharmacology of traumatic brain injury: where is the "golden bullet"? Mol. Med. 14, 731-740.
2. Mustafa, A.G. and Alshboul, O.A. (2013). Pathophysiology of traumatic brain injury. Neurosciences (Riyadh) 18, 222-234.
3. Greve, M.W. and Zink, B.J. (2009). Pathophysiology of traumatic brain injury. Mt Sinai J Med 76, 97-104.
4. Jin, K. and Galvan, V. (2007). Endogenous neural stem cells in the adult brain. J Neuroimmune Pharmacol. 2, 236-242.
5. Bagrov, A.Y., Shapiro, J.I., and Fedorova, O.V. (2009). Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol. Rev. 61, 9-38.
6. Wasserstrom, J.A. and Aistrup, G.L. (2005). Digitalis: new actions for an old drug. Am. J. Physiol. Heart. Circ. Physiol. 289, H1781-H1793.
7. Bauman, J.L., Didomenico, R.J., and Galanter, W.L. (2006). Mechanisms, manifestations, and management of digoxin toxicity in the modern era. Am. J. Cardiovasc. Drugs. 6, 77-86.
8. Furstenwerth, H. (2010). Ouabain - the insulin of the heart. Int. J. Clin. Pract. 64, 1591-1594.
9. Blanco, G. and Mercer, R.W. (1998). Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am. J. Physiol. 275, F633-F650.
10. Kaplan, J.H. (2002). Biochemistry of Na,K-ATPase. Annu. Rev. Biochem. 71, 511-535.
11. Liu, J. and Xie, Z.J. The sodium pump and cardiotonic steroidsinduced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking. Biochim. Biophys. Acta 1802, 1237-1245.
12. Xie, Z. and Askari, A. (2002). Na(+)/K(+)-ATPase as a signal transducer. Eur. J. Biochem. 269, 2434-2439.
13. Matsumoto, S., Kitagawa, J., and Takeda, M. (2008). The effects of ouabain on resting membrane potential and hyperpolarizationactivated current in neonatal rat nodose ganglion neurons. Neurosci. Lett. 439, 241-244.
14. Lichtstein, D. and Rosen, H. (2001). Endogenous digitalis-like Na+, K+-ATPase inhibitors, and brain function. Neurochem. Res. 26, 971-978.
15. de Rezende Correa, G., Araujo dos Santos, A., Frederico Leite Fontes, C., and Giestal de Araujo, E. (2005). Ouabain induces an increase of retinal ganglion cell survival in vitro: the involvement of protein kinase C. Brain Res. 1049, 89-94.
16. Murata, Y., Matsuda, T., Tamada, K., Hosoi, R., Asano, S., Takuma, K., Tanaka, K., and Baba, A. (1996). Ouabain-induced cell proliferation in cultured rat astrocytes. Jpn. J. Pharmacol. 72, 347-353.
17. Dvela, M., Rosen, H., Ben-Ami, H.C., and Lichtstein, D. (2012). Endogenous ouabain regulates cell viability. Am. J. Physiol. Cell. Physiol. 302, C442-C452.
18. Sibarov, D.A., Bolshakov, A.E., Abushik, P.A., Krivoi, II, and Antonov, S.M. (2012). Na+,K-ATPase functionally interacts with the plasma membrane Na+,Ca2+ exchanger to prevent Ca2+ overload and neuronal apoptosis in excitotoxic stress. J. Pharmacol. Exp. Ther. 343, 596-607.
19. Qiu, J., Gao, H.Q., Zhou, R.H., Liang, Y., Zhang, X.H., Wang, X.P., You, B.A. and Cheng, M. (2007). Proteomics analysis of the proliferative effect of low-dose ouabain on human endothelial cells. Biol. Pharm. Bull. 30, 247-253.
20. Wang, J.K., Portbury, S., Thomas, M.B., Barney, S., Ricca, D.J., Morris, D.L., Warner, D.S., and Lo, D.C. (2006). Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform. Proc. Natl. Acad. Sci. U. S. A. 103, 10461-10466.
21. Oselkin, M., Tian, D., and Bergold, P.J. (2010). Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia. Neurosci. Lett. 473, 67-71.
22. Chen, Y., Constantini, S., Trembovler, V., Weinstock, M., and Shohami, E. (1996). An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J. Neurotrauma 13, 557-568.
23. Flierl, M.A., Stahel, P.F., Beauchamp, K.M., Morgan, S.J., Smith, W.R., and Shohami, E. (2009). Mouse closed head injury model induced by a weight-drop device. Nat. Protoc. 4, 1328-1337.
24. Beni-Adani, L., Gozes, I., Cohen, Y., Assaf, Y., Steingart, R.A., Brenneman, D.E., Eizenberg, O., Trembolver, V., and Shohami, E. (2001). A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther. 296, 57-63.
25. Tsenter, J., Beni-Adani, L., Assaf, Y., Alexandrovich, A.G., Trembovler, V., and Shohami, E. (2008). Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2- weighted MRI abnormalities, and motor and cognitive functions. J. Neurotrauma 25, 324-333.
26. Swanson, R.A., Morton, M.T., Tsao-Wu, G., Savalos, R.A., Davidson, C., and Sharp, F.R. (1990). A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10, 290-293.
27. Jin, K., Minami, M., Lan, J.Q., Mao, X.O., Batteur, S., Simon, R.P., and Greenberg, D.A. (2001). Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc. Natl. Acad. Sci. U. S. A. 98, 4710-4715.
28. Nesher, M., Shpolansky, U., Rosen, H., and Lichtstein, D. (2007). The digitalis-like steroid hormones: new mechanisms of action and biological significance. Life Sci. 80, 2093-2107.
29. Gao, J., Wymore, R.S., Wang, Y., Gaudette, G.R., Krukenkamp, I.B., Cohen, I.S., and Mathias, R.T. (2002). Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides. J. Gen. Physiol. 119, 297-312.
30. Lichtstein, D., Samuelov, S., and Bourrit, A. (1985). Characterization of the stimulation of neuronal Na(+), K(+)-ATPase activity by low concentrations of ouabain. Neurochem. Int. 7, 709-715.
31. Lima, F.D., Souza, M.A., Furian, A.F., Rambo, L.M., Ribeiro, L.R., Martignoni, F.V., Hoffmann, M.S., Fighera, M.R., Royes, L.F., Oliveira, M.S., and de Mello, C.F. (2008). Na+,K+-ATPase activity impairment after experimental traumatic brain injury: relationship to spatial learning deficits and oxidative stress. Behav. Brain Res. 193, 306-310.
32. Liu, J. and Xie, Z.J. (2010). The sodium pump and cardiotonic ste-roids- induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking. Biochim. Biophys. Acta 1802, 1237-1245.
33. Shein, N.A., Tsenter, J., Alexandrovich, A.G., Horowitz, M., and Shohami, E. (2007). Akt phosphorylation is required for heat acclimation-induced neuroprotection. J. Neurochem. 103, 1523-1529.
34. Cohen-Yeshurun, A., Trembovler, V., Alexandrovich, A., Ryberg, E., Greasley, P.J., Mechoulam, R., Shohami, E. and Leker, R.R. (2011). N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis. J. Cereb. Blood Flow Metab. 31, 1768-1777.
35. Shioda, N., Han, F. and Fukunaga, K. (2009). Role of Akt and ERK signaling in the neurogenesis following brain ischemia. Int. Rev. Neurobiol. 85, 375-387.
36. Cuny, G.D. (2009). Kinase inhibitors as potential therapeutics for acute and chronic neurodegenerative conditions. Curr. Pharm. Des. 15, 3919-3939.
37. Compagnone, N.A. and Mellon, S.H. (2000). Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol. 21, 1-56.
38. Lichtstein, D., Minc, D., Bourrit, A., Deutsch, J., Karlish, S.J., Belmaker, H., Rimon, R., and Palo, J. (1985). Evidence for the presence of 'ouabain like' compound in human cerebrospinal fluid. Brain Res. 325, 13-19.